Guillain-Barré syndrome diagnostic study of choice: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 7: Line 7:


=== Diagnostic Criteria ===
=== Diagnostic Criteria ===
* There is no single diagnostic study of choice for Guillain Barre syndrome, though GBS may be diagnosed based on NINDS criteria established by National Institute of Neurological Disorders and Stroke:<ref name="pmid2194422">{{cite journal |vauthors=Asbury AK, Cornblath DR |title=Assessment of current diagnostic criteria for Guillain-Barré syndrome |journal=Ann. Neurol. |volume=27 Suppl |issue= |pages=S21–4 |date=1990 |pmid=2194422 |doi= |url=}}</ref>
* There is no single diagnostic study of choice for Guillain Barre syndrome, though GBS may be diagnosed based on NINDS criteria established by National Institute of Neurological Disorders and Stroke:<ref name="pmid2194422">{{cite journal |vauthors=Asbury AK, Cornblath DR |title=Assessment of current diagnostic criteria for Guillain-Barré syndrome |journal=Ann. Neurol. |volume=27 Suppl |issue= |pages=S21–4 |date=1990 |pmid=2194422 |doi= |url=}}</ref><ref name="pmid677829">{{cite journal |vauthors= |title=Criteria for diagnosis of Guillain-Barré syndrome |journal=Ann. Neurol. |volume=3 |issue=6 |pages=565–6 |date=June 1978 |pmid=677829 |doi=10.1002/ana.410030628 |url=}}</ref>
** Progressive ascending weakness or paralysis usually starting from legs, involving are 4 limbs, the trunk, bulbar and facial muscles, and external ocular muscles.
** Progressive ascending weakness or paralysis usually starting from legs, involving are 4 limbs, the trunk, bulbar and facial muscles, and external ocular muscles.
** Areflexia or decreased reflexes in affected limbs.
** Areflexia or decreased reflexes in affected limbs.

Revision as of 18:50, 18 December 2018

Guillain-Barré syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Guillain-Barré syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Guillain-Barré syndrome diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Guillain-Barré syndrome diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Guillain-Barré syndrome diagnostic study of choice

CDC on Guillain-Barré syndrome diagnostic study of choice

Guillain-Barré syndrome diagnostic study of choice in the news

Blogs on Guillain-Barré syndrome diagnostic study of choice

Directions to Hospitals Treating Guillain-Barré syndrome

Risk calculators and risk factors for Guillain-Barré syndrome diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Diagnostic Study of Choice

Diagnostic Criteria

  • There is no single diagnostic study of choice for Guillain Barre syndrome, though GBS may be diagnosed based on NINDS criteria established by National Institute of Neurological Disorders and Stroke:[1][2]
    • Progressive ascending weakness or paralysis usually starting from legs, involving are 4 limbs, the trunk, bulbar and facial muscles, and external ocular muscles.
    • Areflexia or decreased reflexes in affected limbs.
  • these findings can make the GBS diagnosis even more possible:
    • Progression of symptoms over days to four weeks
    • Relative symmetry
    • Sensory abnormalities
    • Cranial nerve involvement, especially bilateral facial nerve weakness
    • Recovery starting two to four weeks after progression stops
    • Autonomic disturbance
    • Pain
    • absence of fever in the acute phase
    • Elevated CSF protein level
    • CSF cell count ≤50/mm3
    • Electrodiagnostic abnormalities consistent with GBS

References

  1. Asbury AK, Cornblath DR (1990). "Assessment of current diagnostic criteria for Guillain-Barré syndrome". Ann. Neurol. 27 Suppl: S21–4. PMID 2194422.
  2. "Criteria for diagnosis of Guillain-Barré syndrome". Ann. Neurol. 3 (6): 565–6. June 1978. doi:10.1002/ana.410030628. PMID 677829.

Template:WH Template:WS